遗传性骨髓增殖瘤的风险会影响造血干细胞
Erik L Bao1,2,3,4, Satish K Nandakumar1,2,3, Xiaotian Liao1,2,3
1Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Nature
|October 15, 2020
概括
遗传因素显著增加了骨髓增殖性瘤 (MPN) 的风险. 这项研究确定了17个MPN风险位点,揭示了MPN易感性,干细胞功能和遗传风险之间的联系.
科学领域:
- 血液学
- 遗传学
- 癌症学
背景情况:
- 骨髓增殖性瘤 (MPN) 是由造血干细胞 (HSC) 突变驱动的血液癌症.
- 虽然MPN具有显著的遗传成分,但其遗传基础基本上尚不清楚.
- 之前的研究发现MPN的遗传风险局部有限.
研究的目的:
- 确定与MPN相关的新遗传风险位置.
- 阐明遗传MPN风险背后的生物机制.
- 研究MPN风险,造血特征和HSC功能之间的关系.
主要方法:
- 进行了大规模的全基因组关联研究 (GWAS),涉及3,797例MPN病例和1,152,977例对照病例.
- 分析了MPN风险和各种造血特征之间的共同遗传结构.
- 进行基因映射和变异对功能测定,以确定与MPN风险有关的关键基因.
主要成果:
- 确定了17个MPN风险位点,其中7个是新报告的.
- 在MPN风险和独特的造血特征之间发现了共同的遗传结构.
- 在可访问的HSC染色体中证明了MPN风险变异的丰富性和与更长的端粒长度的关联.
- 确定CHEK2和GFI1B是调节HSC功能并赋予MPN风险的基因.
结论:
- 遗传MPN风险受到调节HSC功能和自我更新的遗传因素的显著影响.
- 这项研究揭示了遗传MPN风险的新机制.
- 这些研究结果为了解多核瘤的遗传基础和制定有针对性的干预措施提供了基础.
更多相关视频
06:39Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
10.0K
07:01Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
Published on: May 2, 2025
539
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.6K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.6K
Stem Cell Therapy for Tissue Regeneration
4.5K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.5K
Regulation of Hematopoietic Stem Cells
3.7K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.7K
Bone Marrow Sampling and Transplants
685
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
685
Lineage Commitment
3.8K
Commitment is the process whereby stem cells:
3.8K
Hematopoiesis
7.9K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.9K
